Anavex Reports Fiscal First Quarter 2017 Financial Results

Go back to Anavex Reports Fiscal First Quarter 2017 Financial Results

Noble Financial Starts Anavex Life Sciences (AVXL) at Buy, PT $16

February 7, 2017 7:27 AM EST

Noble Financial initiated coverage on Anavex Life Sciences (NASDAQ: AVXL) with a Buy rating and a price target of $16.

For an analyst ratings summary and ratings history on Anavex Life Sciences... More